ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LATCHAIAH CHIRUMAMILLA M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,378Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 783

$1.37M Total Retail Price of All Prescriptions

Rank: 14 out of 783

600 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 600 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

31% of this provider’s 600 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 18,752 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,212 819 S3 1 2
FUROSEMIDE 1,116 923 2 7
OMEPRAZOLE 1,006 737 3 6
LEVOTHYROXINE SODIUM 755 554 4 1
ATENOLOL 710 507 5 17
POTASSIUM CHLORIDE 689 555 6 16
LISINOPRIL 683 513 7 4
SIMVASTATIN 460 373 8 3
NAMENDA 457 407 9 32
DONEPEZIL HCL 407 357 10 24
AMLODIPINE BESYLATE 405 331 11 5
PRAVASTATIN SODIUM 401 249 12 14
WARFARIN SODIUM 390 279 13 10
ATORVASTATIN CALCIUM 342 254 14 11
ISOSORBIDE MONONITRATE ER 328 281 15 40
METFORMIN HCL 273 152 16 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 272 159 17 33
GABAPENTIN 264 161 18 15
TAMSULOSIN HCL 256 199 19 26
POLYETHYLENE GLYCOL 3350 255 189 20 43
METOPROLOL TARTRATE 254 206 21 9
DIVALPROEX SODIUM 245 157 22 72
SERTRALINE HCL 241 176 23 22
HYDROCHLOROTHIAZIDE 225 151 24 12
RANITIDINE HCL 223 152 25 44
PROMETHAZINE HCL 213 153 R 26 97
TRAZODONE HCL 212 135 27 39
HYDRALAZINE HCL 209 183 28 78
LANTUS 207 189 29 38
MIRTAZAPINE 207 196 29 52
FLUOXETINE HCL 188 85 31 45
CLOPIDOGREL 184 159 32 29
PROAIR HFA 184 64 32 56
CITALOPRAM HBR 184 101 32 19
AZITHROMYCIN 180 122 35 41
METOPROLOL SUCCINATE 176 162 36 13
ALLOPURINOL 172 116 37 31
QUETIAPINE FUMARATE 172 140 37 79
ZOLPIDEM TARTRATE 168 100 39 23
TRAMADOL HCL 168 134 39 20
NEXIUM 165 108 41 28
PANTOPRAZOLE SODIUM 163 130 42 30
MELOXICAM 162 127 43 37
NAPROXEN 153 93 44 104
KLOR-CON 10 152 95 45 102
PREDNISONE 150 93 46 36
ROPINIROLE HCL 145 114 47 74
GLIMEPIRIDE 141 77 48 34
CYCLOBENZAPRINE HCL 136 78 R 49 63
NITROFURANTOIN MONO-MACRO 134 112 50 174
TRIAMTERENE-HCTZ 133 96 51 42
OXYBUTYNIN CHLORIDE ER 131 108 52 117
CYMBALTA 130 74 53 35
LACTULOSE 126 78 54 169
VERAPAMIL ER 126 123 54 119
AMOXICILLIN 124 78 56 116
SULFAMETHOXAZOLE-TRIMETHOPRIM 121 75 57 95
CARVEDILOL 121 102 57 21
DIGOXIN 118 105 59 61
RISPERIDONE 117 92 60 67
CIPROFLOXACIN HCL 114 90 61 62
CEPHALEXIN 113 79 62 70
KLOR-CON M10 111 87 63 137
PLAVIX 111 92 63 51
SPIRIVA 108 34 65 59
METOCLOPRAMIDE HCL 107 49 66 121
CARBIDOPA-LEVODOPA 107 84 66 88
NYSTATIN 106 85 68 106
ESCITALOPRAM OXALATE 105 69 69 54
LOVAZA 98 60 70 163
NOVOLOG 94 67 71 81
ALENDRONATE SODIUM 92 54 72 25
CLONIDINE HCL 85 56 73 60
ADVAIR DISKUS 85 41 73 50
METHOCARBAMOL 85 53 R 73 215
FENTANYL 82 38 S2 76 65
AMIODARONE HCL 81 78 77 175
BUMETANIDE 81 42 77 131
EVISTA 81 58 77 92
HUMALOG 80 64 80 101
LAMOTRIGINE 79 42 81 156
PAROXETINE HCL 79 66 81 69
SINGULAIR 77 41 83 90
SPIRONOLACTONE 75 47 84 57
PHENYTOIN SODIUM EXTENDED 74 37 85 141
ALBUTEROL SULFATE 73 69 86 136
SEROQUEL 73 50 86 183
TERAZOSIN HCL 71 54 88 130
ALPRAZOLAM 70 44 89 145
ENALAPRIL MALEATE 69 65 90 68
CEFTRIAXONE 68 42 91 227
KLOR-CON M20 68 58 91 48
THEOPHYLLINE ANHYDROUS 65 50 93 219
CRESTOR 64 36 94 27
IPRATROPIUM-ALBUTEROL 64 54 94 110
GEMFIBROZIL 64 30 94 105
OXYCODONE HCL-ACETAMINOPHEN 64 41 S2 94 86
FAMOTIDINE 61 52 98 55
GLIPIZIDE 60 60 99 71
FENOFIBRATE 59 41 100 66
ESTRADIOL 59 43 R 100 204
LIPITOR 57 44 102 114
DICYCLOMINE HCL 57 18 102 200
IBUPROFEN 57 22 102 115
INSULIN SYRINGE 56 42 105 82
BUSPIRONE HCL 56 34 105 124
HALOPERIDOL 55 46 107 216
EXELON 55 44 107 109
DIOVAN 55 33 107 49
CLOTRIMAZOLE-BETAMETHASONE 54 40 110 189
OLANZAPINE 54 40 110 108
LOPERAMIDE 54 43 110 244
CARAFATE 53 34 113 358
COMBIVENT 53 41 113 120
NOVOLIN 70-30 53 49 113 227
FLUTICASONE PROPIONATE 52 27 116 46
FLUCONAZOLE 52 28 116 179
NYSTOP 51 33 118 231
TOPIRAMATE 51 12 118 152
SUCRALFATE 51 34 118 190
MECLIZINE HCL 50 35 121 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.